-+ 0.00%
-+ 0.00%
-+ 0.00%

Spyglass Pharma FY2025 net loss widens 37% to $(40) million; general and administrative expense jumps 73% to $12 million

Reuters·03/26/2026 21:24:19

Please log in to view news